Christopher Hartl chartl1

In my tenure in bioinformatics, I have transitioned from a role as a developer at Citeline, Inc. to serving as Chief Technology Officer at Epigenome Technologies, Inc. My efforts have included contributing to the development of analytical tools in genetic research at The Broad Institute and engaging in machine learning projects at SynapDx. Presently, at Epigenome Technologies, I am part of a team focused on the development of single-nucleus multi-omic technologies, aiming to enhance the capabilities of genomic data analysis. Education: UCLA Doctor of Philosophy, Bioinformatics 2014 - 2019 Laboratory of Dr. Dan Geschwind Harvard University BA, Applied MathematicsBA, Applied Mathematics 2005 - 2009 A.B. - Applied Mathematics with application to Computational Neuroscience

San Diego, CA, US

Chief Technology Officer

Bioinformatics

Epigenome Technologies

Christopher Hartl (chartl1) page is loading…